In our September issue

Read about health risk assessment of nanopesticides, voltage control of ferrimagnetic order, graphene for color protection in artwork, a three qubit state in silicon, and much more.   

Announcements

  • Picture of authors

    Join Fabio Pulizzi as he discusses about data reuse in nanotechnology during this panel discussion with Desiree Plata (MIT), Penny Nymark (Karolinska Institute), Iseult Lynch (University of Birmingham) and Heike Langenberg (Communications Earth & Environement).

  • banner

    Join Nature Nano and a number of experts to discuss exciting topics in nanotechnology.

    Coming up:

    Nature Nano Talks - Nanotechnology and Global Health - A panel discussion 21st April, 3 pm UK time

Nature Nanotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

  • Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of such advanced nanoscale vaccine technologies compared with clinically established conventional vaccines, and the lessons to be learnt from this potentially transformative development in the adoption and acceptance of nanotechnology for medicine.

    • Thomas Kisby
    • Açelya Yilmazer
    • Kostas Kostarelos
    Comment
  • Sharing the step-by-step procedures necessary to fabricate nanostructures could optimize efforts to achieve reproducible devices.

    • Mohammad J. Bereyhi
    • Tobias J. Kippenberg
    Comment
  • The FAIR principles provide compelling guidelines on how to achieve reusability of nanotechnology data.

    Editorial
  • The challenge of assessing the scope and magnitude of risk from nanomaterials is urgent for society and ignoring risks could be detrimental for development. This challenge is bigger than the individual capacities on each side of the Atlantic, but effective cross-Atlantic collaboration can solve essential riddles about the use of nanomaterials.

    • Janeck James Scott-Fordsmand
    • Mónica João de Barros Amorim
    • Christine Ogilvie Hendren
    Comment
  • Research on nanoplastic has already provided some significant results but it has also exposed a large number of open questions.

    Editorial
When nanotechnology focuses on COVID-19

When nanotechnology focuses on COVID-19

In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research
Focus

Nature Careers

Events

Jobs